Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients

This publication has 21 references indexed in Scilit:

• Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
  The Lancet, 2011
• Functional changes in Duchenne muscular dystrophy
  Neurology, 2011
• Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: Results from a 12 month, double-blind, randomized placebo-controlled trial
  Neuromuscular Disorders, 2011
• Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
  New England Journal of Medicine, 2011
• Choosing the right clinical outcome measure: From the patient to the statistician and back
  Neuromuscular Disorders, 2011
• The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophy
  Muscle & Nerve, 2009
• Clinimetric Properties of Instruments to Assess Activities in Patients With Hand Injury: A Systematic Review of the Literature
  Archives of Physical Medicine and Rehabilitation, 2009
• Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; Report of three expert workshops: TREAT-NMD/ENMC Workshop on outcome measures, 12th–13th May 2007, Naarden, The Netherlands; TREAT-NMD Workshop on outcome measures in experimental trials for DMD, 30th June–1st July 2007, Naarden, The Netherlands; Conjoint Institute of Myology TREAT-NMD Meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France
  Neuromuscular Disorders, 2008
• Hand weakness in Duchenne muscular dystrophy and its relation to physical disability
  Neuromuscular Disorders, 2008
• Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children
  Muscle & Nerve, 2001